Your session is about to expire
← Back to Search
Pivotal Response Treatment for Autism (PRT-HvC Trial)
PRT-HvC Trial Summary
This trial is comparing two different types of therapy for children with autism who have language delays. One group will receive therapy at a center, and the other group will receive therapy at home. There is also a control group who will receive usual treatment.
PRT-HvC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPRT-HvC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PRT-HvC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the protocol for this investigation permit geriatric participants?
"This clinical trial is open to all participants aged between 2 and 5 years old."
For whom is this research endeavor suitable?
"This medical study is currently recruiting 120 individuals aged between two and five who suffer from Autism Spectrum Disorder. Patients must meet the following criteria in order to be eligible: Diagnostic confirmation of ASD through ADI-R, ADOS-2, CARS-2 or DSM-5; male/female ratio 2.0 - 5.11 years old; no major changes in treatment for 1 month prior to baseline measurements; availability of parent(s) able to consistently participate in training and research measures; capacity to undergo testing procedures with valid standard scores produced; language delay as measured by PLS-5 (Standard score at least 1 STD below"
What is the scope of participants included in this research?
"Affirmative. The clinicaltrials.gov records demonstrate that this trial is currently recruiting participants; it was first posted on October 18th 2022 and updated recently on the 25th of October 2022. It requires 120 patients from a single clinic for participation."
Are there vacancies available to participate in this trial?
"Affirmative. Clinicaltrials.gov displays evidence that this medical trial, which initially appeared on October 18th 2022, is still searching for candidates. The study requires 120 participants from a single clinical centre to be enrolled in it."
Share this study with friends
Copy Link
Messenger